Anidulafungin Injection Suppliers & Bulk Manufacturers

Available Forms: Intravenous (IV) Powder

Available Strengths: 50 mg/vial

Reference Brands: Eraxis(US)

Category: Anti-fungal

Anidulafungin injection is available in Intravenous (IV) Powder and strengths such as 50 mg/vial. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Anidulafungin injection is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Anidulafungin injection can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Anidulafungin IV powder is approved in the EU and US for treating invasive fungal infections. In the EU, Pfizer’s Eraxis is regulated by EMA, supported by dossiers demonstrating safety, efficacy, and high manufacturing standards. In the US, FDA approval is based on comprehensive clinical data, biosimilarity assessments, and continuous pharmacovigilance. Both regions require detailed regulatory dossiers for initial approval and ongoing safety monitoring. For expert assistance with pharmaceutical dossiers, regulatory submissions, and compliance, visit PharmaTradz. We support efficient market access for anidulafungin IV formulations, ensuring adherence to European and American standards for safe, effective antifungal therapy.